We have successfully treated over 700 patients with stem cell therapy
Here at Macquarie Stem Cells in Sydney we are passionate about cellular therapy and the life-changing effects that the treatment can provide. Cellular therapy is a delicate process that introduces new cells into living tissue in order to treat disease. Delicate treatments such as this need to be implemented by a team of stem cell professionals who will work hard to treat patients with care, compassion and superior service. At Macquarie Stem Cells we combine a stellar team with the highest level of stem cell therapy to invigorate the body’s natural renewal process. By harnessing the power of stem cells (SVF cells) we are able to improve the effects of osteoarthritis.
Macquarie Stem Cells has access to the finest stem cell professionals in Australia, meet our team…
Dr Ralph Bright MB ChB FFMACC
About Dr. Ralph Bright
Dr Ralph Bright practices as a Stem Cell Physician and Cosmetic Surgeon with an interest in Anti-Ageing Medicine. He was the first doctor in Australia to inject stem cells in April 2009. Since then he has continued to refine the procedures and protocols yielding greater numbers of stem cells and better results for patients. He is a founding director of Cell-Innovations, a research and development company that has developed and patented an ultrasonic cavitation method for separating stem cells from fat. This technology is now being sold to companies in Australia and around the world.
Many diseases have been treated. The greatest success so far has been with Osteoarthritis. Trial applications are being submitted to study other diseases that have shown promise in Pilot studies.
The application of stem cells to cosmetic surgery has been slower to elucidate but we are now unraveling the connection between PRP, Fat and stem cells. The stem cell facelift and stem cells for hair regrowth are showing great promise. As we learn better how to use them they will blossom. There has been an explosion in ‘Stem Cell Creams’. Dr Bright will present on this topic at the next Cosmetex conference in Melbourne.
He has a strong interest in research and a passionate belief in the industry He has been invited to present his work at many conferences in Australia and around the world.
Dr Bright received a Parliamentary Commendation in 2013 for his contribution to Stem Cell therapy and research.
Dr Bright is a member of the following organisations:
- International Federation for Adipose Therapeutics and Science (IFATS)
- International Cellular Medicine Society (ICMS)
- Cosmetic Physicians Society of Australasia (CPSA)
- Executive Member of the Australian Autologous Cell Therapy
- Consortiums (AACTC) writing the Code of Conduct for Cellular Therapy in Australia
- Fellow of the Faculty of Medicine ACCS
- Member Australasian College of Cosmetic Surgery
- Member Cosmetic Physicians Society of Australasia
- Member International Federation of Adipose Therapeutics and Science
- Member The American Society of Cosmetic Breast Surgery
- Member International Cellular Medicine Society
At Macquarie Stem Cells, we have worked, and continue to work extensively with Cell-Innovations, an Australian-owned company involved in developing and commercialising cutting-regenerative medical technologies, to develop and test our own knowledge and procedures.
In an independent university study, the team at Macquarie Stem Cells worked closely with Cell-Innovations on stem cell viability and differentiation on Stromal Vascular Fraction (SVF) separation.
These studies validated Cell-Innovations sonication protocol to obtain viable, adherent cells capable of mitotic division and differentiation indicative of mesenchymal stem cells.
The Cell-Innovations proprietary technology has been used in clinical practice since 2012, and looks set to help shape the future of therapeutic approaches to musculoskeletal conditions such as osteoarthritis. Cell-Innovations is at the forefront of improving patients lives with Regenerative Medicine, which is why the team at Macquarie Stem Cells strive toward developing and testing our technologies to ensure optimal outcomes for all patients.